Loading ...
ubcnewsworld
Business & Economics
6
0
Try Now
Log In
Pricing
Endocrine tumor surgery should not be delayed by surge in Covid's Delta variant With cases of COVID-19 surging in all 50 states and many foreign countries, surgeons and hospitals with high volumes of elective surgery are concerned that patients will once again put off their knee replacement or other procedure that isn’t absolutely necessary. "We aren’t seeing this at all. Patients with thyroid, parathyroid, and adrenal tumors often feel miserable, and they do not want to put off an operation that will make them feel better, and of course, they do not want to delay having their thyroid cancer cured" says Dr Jim Norman The Norman/Clayman Endocrine Institute in Tampa, FL announced that new patient referrals for thyroid, parathyroid and adrenal surgery have reached an all-time high, despite fears of another pandemic spike. This is in contrast to some other forms of elective surgery, such as knee and hip replacements, which have not fully recovered from the dramatic shut down of 2020. The Norman/Clayman Endocrine institute is the world’s highest volume center for surgery of thyroid, parathyroid and adrenal tumors and cancers. The institute includes the following specialty centers: The Norman Parathyroid Center, the Clayman Thyroid Cancer Center and the Carling Adrenal Center. “The patients are coming from all 50 states and from 14 foreign countries in just the past few weeks,” said Dr Norman. “These are numbers we have never seen before, showing that patients with endocrine tumors are not going to wait like they were forced to last year." "The fear of delayed cancer surgery potentially leading to lower cure rates and more advanced disease has many patients unwilling to put off endocrine surgery. “Many patients operated on over the past 9 months are frustrated and angry that their cancer surgery was delayed” “Endocrine surgery has two distinct advantages over many other operations that have been lumped together under the term ‘elective’," continued Dr. Norman, who is the CEO of the Norman/Clayman Endocrine Institute. "The first is the lack of need for overnight stay in most cases, and the second is that patients with endocrine tumors and cancers won’t let their operations be delayed again. They have learned their lesson and they are quite vocal about it online.” Contact Us At: parathyroid.com or call: +1-813-972-0000
